...
首页> 外文期刊>Human Molecular Genetics >Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly
【24h】

Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly

机译:钙敏感受体在内质网中二聚化:细胞内保留的CASR突变体的生化和生物物理特征

获取原文
获取原文并翻译 | 示例

摘要

Calcium-sensing receptor (CASR), expressed in parathyroid gland and kidney, is a critical regulator of extracellular calcium homeostasis. This G protein-coupled receptor exists at the plasma membrane as a homodimer, although it is unclear at which point in the biosynthetic pathway dimerization occurs. To address this issue, we have analyzed wild-type and mutant CASRs harboring R66H, R66C or N583X-inactivating mutations identified in familial hypocalciuric hypercalcemiaeonatal severe hyperparathyroid patients, which were transiently expressed in kidney cells. All mutants were deficient in cell signaling responses to extracellular CASR ligands relative to wild-type. All mutants, although as well expressed as wild-type, lacked mature glycosylation, indicating impaired trafficking from the endoplasmic reticulum (ER). Dimerized forms of wild-type, R66H and R66C mutants were present, but not of the N583X mutant. By immunofluorescence confocal microscopy of non-permeabilized cells, although cell surface expression was observed for the wild-type, little or none was seen for the mutants. In permeabilized cells, perinuclear staining was observed for both wild-type and mutants. By colocalization fluorescence confocal microscopy, the mutant CASRs were localized within the ER but not within the Golgi apparatus. By the use of photobleaching fluorescence resonance energy transfer microscopy, it was demonstrated that the wild-type, R66H and R66C mutants were dimerized in the ER, whereas the N583X mutant was not. Hence, constitutive CASR dimerization occurs in the ER and is likely to be necessary, but is not sufficient, for exit of the receptor from the ER and trafficking to the cell surface.
机译:在甲状旁腺和肾脏中表达的钙敏感受体(CASR)是细胞外钙稳态的关键调节剂。尽管尚不清楚在生物合成途径中的哪一点发生二聚化,但这种G蛋白偶联受体作为同二聚体存在于质膜上。为解决此问题,我们分析了携带R66H,R66C或N583X失活突变的野生型和突变型CASR,这些突变在家族性低钙血症/新生儿重度甲状旁腺功能亢进患者中鉴定,并在肾细胞中瞬时表达。相对于野生型,所有突变体对细胞外CASR配体的细胞信号传导反应均不足。尽管所有突变体均表现为野生型,但它们都缺乏成熟的糖基化,表明从内质网(ER)的运输受到损害。存在野生型R6​​6H和R66C突变体的二聚体形式,但不存在N583X突变体。通过非透化细胞的免疫荧光共聚焦显微镜观察,尽管观察到野生型细胞表面表达,但几乎没有或没有观察到突变体。在透化细胞中,野生型和突变体均观察到核周染色。通过共定位荧光共聚焦显微镜,突变的CASR位于ER内,而不位于高尔基体中。通过使用光漂白荧光共振能量转移显微镜,证明了野生型,R66H和R66C突变体在ER中是二聚体,而N583X突变体不是。因此,组成型CASR二聚化发生在ER中,并且可能是必需的,但不足以使受体从ER中出来并运输到细胞表面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号